Methicillin-resistant Staphylococcus aureus (MRSA), also known as oxacillin-resistant Staphylococcus aureus (ORSA), multiple-resistant Staphylococcus aureus, CA-MRSA (community-acquired MRSA) and HA-MRSA (hospital-acquired MRSA), is a biological agent responsible for difficult-to-treat infections in humans. (MSSA is Methicillin-susceptible Staphylococcus aureus.)
Whiter laundry and a surprising new treatment for kids’ eczema. Bleach baths clear the rash and banish flare-ups of miserable skin disease. – It’s best known for whitening a load of laundry. But now simple household bleach has a surprising new role: an effective treatment for kids’ chronic eczema.
Queen’s scientists find new way to battle MRSA – Experts from Queen’s University Belfast have developed new agents to fight MRSA and other hospital-acquired infections that are resistant to antibiotics.
Researchers have uncovered the workings of a superbug that kills elderly hospital patients worldwide. – An international team of scientists, led by Monash University researchers, has uncovered the workings of a superbug that kills elderly hospital patients worldwide – a discovery that has the potential to save lives and health care systems billions of dollars each year.
Swimmers at public beaches show increased risk of exposure to contagious staph bacteria and MRSA. – Swimmers using public ocean beaches increase their risk for exposure to staph organisms, and may increase their risk for potential staph infections once they enter the water.
Researchers have discovered a way of using tiny nano-probes to help understand how an antibiotic is effective against bacteria. – A group of researchers led by scientists from the London Centre for Nanotechnology, in collaboration with a University of Queensland researcher, have discovered a way of using tiny nano-probes to help understand how an antibiotic is effective against bacteria.
MRSA pre-screening effective in reducing otolaryngic surgical infection rates, revealed by researchers in Otolaryngology ? Head and Neck Surgery. – Pre-operative screening of patients for methicillin-resistant staphylococcus aureus (MRSA) may be an effective way to reduce infection rates following otolaryngic surgeries, according to new research published in the January 2009 issue of Otolaryngology ? Head and Neck Surgery.
A new study by a team of researchers at the Welsh School of Pharmacy, Cardiff University, Wales, UK, has found that antimicrobial-containing wipes currently used to decontaminate surfaces in hospitals can spread pathogens after first use. – Antimicrobial-containing wipes currently used to decontaminate surfaces in hospitals can spread pathogens after first use, revealed by researchers at the Welsh School of Pharmacy, Cardiff University, Wales, UK.
Community acquired pneumonia (CAP) caused by the Staphylococcus aureus bacterium may be more common than originally suspected, including that caused by antibiotic resistant strains. – Preliminary research from the Centers for Disease Control and Prevention (CDC) suggests that community acquired pneumonia (CAP) caused by the Staphylococcus aureus bacterium may be more common than originally suspected, including that caused by antibiotic resistant strains.
Methicillin-resistant S aureus?positive surgical site infection is an increasingly problematic issue in all surgical fields. In the future, MRSA-positive infections will be more prevalent and will require well-developed screening, prevention, and treatment strategies. – About one-half percent of patients undergoing facelift surgery at one outpatient surgical center between 2001 and 2007 developed methicillin-resistant Staphylococcus aureus (MRSA) infections, according to a report in the March/April issue of Archives of Facial Plastic Surgery, one of the JAMA/Archives journals.
A universal, rapid MRSA admission screening strategy did not reduce nosocomial MRSA infection in a surgical department with endemic MRSA prevalence but relatively low rates of MRSA infection. – New findings do not support the recommendation for universal screening on hospital admission for methicillin-resistant Staphylococcus aureus (MRSA) to reduce the rate of hospital-acquired infections in surgical patients, according to a study in the March 12 issue of JAMA.
This is the fourth annual report on deaths in England and Wales involving MRSA and the third annual report on deaths involving Clostridium difficile. Data for 2006 are published for the first time. – The number of deaths involving Clostridium difficile continued to rise between 2005 and 2006, while deaths involving MRSA levelled out, according to new figures published by the Office for National Statistics in Health Statistics Quarterly 37 spring 2008.
Rates of MRSA infection in injection drug users in Vancouver have significantly increased over the last six years. – A new comparative study suggests that rates of MRSA infection in injection drug users in Vancouver have significantly increased over the last six years highlighting the need for interventional methods in high-risks groups.
